Product Code: ETC6193216 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 | |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Australia Type 2 Diabetes Market Overview |
3.1 Australia Country Macro Economic Indicators |
3.2 Australia Type 2 Diabetes Market Revenues & Volume, 2021 & 2031F |
3.3 Australia Type 2 Diabetes Market - Industry Life Cycle |
3.4 Australia Type 2 Diabetes Market - Porter's Five Forces |
3.5 Australia Type 2 Diabetes Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Australia Type 2 Diabetes Market Revenues & Volume Share, By Application, 2021 & 2031F |
4 Australia Type 2 Diabetes Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of obesity in Australia leading to a higher risk of type 2 diabetes |
4.2.2 Growing awareness about the importance of early diagnosis and management of type 2 diabetes |
4.2.3 Technological advancements in diabetes management devices and treatments |
4.3 Market Restraints |
4.3.1 Rising healthcare costs associated with the treatment and management of type 2 diabetes |
4.3.2 Limited access to specialized healthcare services in remote or rural areas |
4.3.3 Lack of effective preventive measures to reduce the incidence of type 2 diabetes |
5 Australia Type 2 Diabetes Market Trends |
6 Australia Type 2 Diabetes Market, By Types |
6.1 Australia Type 2 Diabetes Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Australia Type 2 Diabetes Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 Australia Type 2 Diabetes Market Revenues & Volume, By Insulins, 2021- 2031F |
6.1.4 Australia Type 2 Diabetes Market Revenues & Volume, By DPP-4 Inhibitors, 2021- 2031F |
6.1.5 Australia Type 2 Diabetes Market Revenues & Volume, By GLP-1 Receptor Agonists, 2021- 2031F |
6.1.6 Australia Type 2 Diabetes Market Revenues & Volume, By SGLT-2 Inhibitors, 2021- 2031F |
6.2 Australia Type 2 Diabetes Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Australia Type 2 Diabetes Market Revenues & Volume, By Drugstore, 2021- 2031F |
6.2.3 Australia Type 2 Diabetes Market Revenues & Volume, By Hospital, 2021- 2031F |
6.2.4 Australia Type 2 Diabetes Market Revenues & Volume, By Others, 2021- 2031F |
7 Australia Type 2 Diabetes Market Import-Export Trade Statistics |
7.1 Australia Type 2 Diabetes Market Export to Major Countries |
7.2 Australia Type 2 Diabetes Market Imports from Major Countries |
8 Australia Type 2 Diabetes Market Key Performance Indicators |
8.1 Percentage of the population screened for type 2 diabetes regularly |
8.2 Adoption rate of new diabetes management technologies and treatments |
8.3 Percentage of patients achieving target HbA1c levels |
8.4 Average time from diagnosis to initiation of treatment |
8.5 Rate of hospital admissions due to diabetes-related complications |
9 Australia Type 2 Diabetes Market - Opportunity Assessment |
9.1 Australia Type 2 Diabetes Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Australia Type 2 Diabetes Market Opportunity Assessment, By Application, 2021 & 2031F |
10 Australia Type 2 Diabetes Market - Competitive Landscape |
10.1 Australia Type 2 Diabetes Market Revenue Share, By Companies, 2024 |
10.2 Australia Type 2 Diabetes Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |